Skip to content

Intervention of muscle-building and anti-frailty exercise combined with Baduanjin for frailty of different functional levels: study protocol for a randomized controlled trial

Intervention of muscle-building and anti-frailty exercise combined with Baduanjin for frailty of different functional levels

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070535
Enrollment
Unknown
Registered
2023-04-14
Start date
2023-05-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty

Interventions

Experimental group:muscle-building and anti-frailty exercise
Control group:health education

Sponsors

The Second Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 70 years old; 2. Diagnosed as asthenic or pre-asthenic; 3. Volunteer to participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment; 2. Severe loss of vision and hearing, unable to communicate normally; 3. Those who have suffered from major diseases or have not recovered from major surgery within the past six months; 4. Acute stage of various diseases or stage of severe functional failure, such as acute infection, gastrointestinal bleeding, heart failure, respiratory failure, renal failure, etc.; 5. People with diabetes (fasting blood sugar level > 125 mg/dl), high blood pressure, and heart disease that have not been effectively controlled; 6. Patients whose functional tests are affected by pain in limb joints, bones, muscles, etc.; 7. Patients with internal metal implants such as cardiac pacemakers and artificial joints.

Design outcomes

Primary

MeasureTime frame
Short Physical Performance Battery (SPPB);Fried scale score;

Secondary

MeasureTime frame
body composition;Activities of daily living (ADL);Mini-Mental State Examination (MMSE);The Geriatric Depression Scale (GDS-15);Interleukin-6;Tumor necrosis factor-alpha;Chemokine -9;cystatin C;Vitamin D;Insulin growth factor 1;

Countries

China

Contacts

Public ContactPeng Nan

The Second Medical Center, Chinese PLA General Hospital, Beijing, China

pengnan301@163.com+86 13683012895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026